Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus

ConclusionThis study concludes that oral cyclophosphamide pulse therapy is an economical option and there was no difference in efficacy and safety between oral cyclophosphamide pulse therapy and IV pulse cyclophosphamide therapy.

https://onlinelibrary.wiley.com/doi/abs/10.1111/1756-185X.13823?af=R

Source: International Journal of Rheumatic Diseases - May 24, 2020 Category: Rheumatology Authors: Shivraj Padiyar, Suvrat Arya, Ajit Surin, Vishad Viswanath, Debashish Danda Tags: ORIGINAL ARTICLE Source Type: research